GOODWILL(SH:688246)2026-02-27 09:00Financial Performance - In 2025, the total operating revenue was RMB 40,766.54 million, a decrease of 31.13% compared to the previous year[4] - The net profit attributable to the parent company was a loss of RMB 25,277.79 million, a reduction in loss of RMB 333.95 million year-on-year[6] - Total assets at the end of the reporting period were RMB 214,103.23 million, down 13.92% from the beginning of the period[6] - The equity attributable to the parent company decreased by 16.29% to RMB 130,196.89 million[5] - The basic earnings per share were RMB -1.84, slightly improved from RMB -1.86 in the previous year[4] - The weighted average return on net assets was -17.69%, a decrease of 2.53 percentage points compared to the previous year[4] - The net asset value per share attributable to the parent company decreased by 16.29% to RMB 9.46[5] Research and Development - The company maintained high R&D investment despite a significant drop in revenue, focusing on AI applications and core product development[9] - The company anticipates that ongoing investments in AI technology will create new business growth points in 2026[9] Revenue Decline Factors - The decline in revenue was attributed to reduced fiscal support for public hospitals and the impact of medical insurance payment reforms[7]